# Gain Therapeutics (GANX): value investors who own it

1 value investor held Gain Therapeutics in their Q3 2026 13F, led by Greenlight Capital. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Greenlight Capital | 0.0% | $1.1m | Unchanged | 22 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/ganx). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.